157 related articles for article (PubMed ID: 38360888)
21. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
[TBL] [Abstract][Full Text] [Related]
22. Identification of potential targets of the curcumin analog CCA-1.1 for glioblastoma treatment : integrated computational analysis and in vitro study.
Hermawan A; Wulandari F; Hanif N; Utomo RY; Jenie RI; Ikawati M; Tafrihani AS
Sci Rep; 2022 Aug; 12(1):13928. PubMed ID: 35977996
[TBL] [Abstract][Full Text] [Related]
23. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
Liu J; Xu K; Ma L; Wang Y
Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
[TBL] [Abstract][Full Text] [Related]
24. Study on the Inhibitory Effect of Curcumin on GBM and Its Potential Mechanism.
Su X; Chen S; Lu H; Li H; Qin C
Drug Des Devel Ther; 2021; 15():2769-2781. PubMed ID: 34234410
[TBL] [Abstract][Full Text] [Related]
25. Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics.
Wang D; Jiang Y; Wang T; Wang Z; Zou F
BMC Med Genomics; 2022 May; 15(1):111. PubMed ID: 35550147
[TBL] [Abstract][Full Text] [Related]
26. Exploration of the Molecular Mechanism of Polygonati Rhizoma in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking.
Zhao J; Lin F; Liang G; Han Y; Xu N; Pan J; Luo M; Yang W; Zeng L
Front Endocrinol (Lausanne); 2021; 12():815891. PubMed ID: 35069454
[TBL] [Abstract][Full Text] [Related]
27. Identification of upregulated genes in glioblastoma and glioblastoma cancer stem cells using bioinformatics analysis.
Caglar HO; Duzgun Z
Gene; 2023 Jan; 848():146895. PubMed ID: 36122609
[TBL] [Abstract][Full Text] [Related]
28. Integrated network pharmacology, bioinformatics, and molecular docking to explore the mechanisms of berberine regulating autophagy in breast cancer.
Huang B; Wen G; Li R; Wu M; Zou Z
Medicine (Baltimore); 2023 Sep; 102(36):e35070. PubMed ID: 37682166
[TBL] [Abstract][Full Text] [Related]
29. Exploring the potential biomarkers for prognosis of glioblastoma via weighted gene co-expression network analysis.
Zhang M; Zhou Z; Liu Z; Liu F; Zhao C
PeerJ; 2022; 10():e12768. PubMed ID: 35111402
[TBL] [Abstract][Full Text] [Related]
30. Discussion on the molecular mechanism of Duhuo Jisheng decoction in treating osteoarthritis based on network pharmacology and molecular docking.
Yang L; Zheng S; Hou A; Wang S; Zhang J; Yu H; Wang X; Lan W
Medicine (Baltimore); 2022 Oct; 101(42):e31009. PubMed ID: 36281111
[TBL] [Abstract][Full Text] [Related]
31. MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by suppressing SDC1 in glioblastoma.
Li G; Ma L; Feng C; Yin H; Bao J; Wu D; Zhang Z; Li X; Li Z; Yang C; Wang H; Fang F; Hu X; Li M; Xu L; Xu Y; Liang H; Yang T; Wang J; Pan J
BMC Cancer; 2024 Feb; 24(1):220. PubMed ID: 38365636
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of the Bushen Huoxue formula in the treatment of osteoarthritis based on network pharmacology-molecular targets.
Pang T; Liu C; Yao J; Li J; Li Z; Lou H; Lei S; Zhang J; Dong L; Wang Y
Medicine (Baltimore); 2022 Aug; 101(32):e29345. PubMed ID: 35960090
[TBL] [Abstract][Full Text] [Related]
33. Multi-omics analysis predicts fibronectin 1 as a prognostic biomarker in glioblastoma multiforme.
Kabir F; Apu MNH
Genomics; 2022 May; 114(3):110378. PubMed ID: 35513291
[TBL] [Abstract][Full Text] [Related]
34. Network pharmacology-based strategy to investigate pharmacological mechanisms of Tinospora sinensis for treatment of Alzheimer's disease.
Zhou F; He K; Guan Y; Yang X; Chen Y; Sun M; Qiu X; Yan F; Huang H; Yao L; Liu B; Huang L
J Ethnopharmacol; 2020 Sep; 259():112940. PubMed ID: 32389853
[TBL] [Abstract][Full Text] [Related]
35. Effects of Vitexin, a Natural Flavonoid Glycoside, on the Proliferation, Invasion, and Apoptosis of Human U251 Glioblastoma Cells.
Huang J; Zhou Y; Zhong X; Su F; Xu L
Oxid Med Cell Longev; 2022; 2022():3129155. PubMed ID: 35281458
[TBL] [Abstract][Full Text] [Related]
36. Exploring the mechanism and experimental validation of Fuzi Lizhong Tang in treating gastric cancer based on network pharmacology and molecular docking.
Zhang FY; Guo SC
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9192-9204. PubMed ID: 37843333
[TBL] [Abstract][Full Text] [Related]
37. Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme.
Liu E; Li W; Jian LP; Yin S; Yang S; Zhao H; Huang W; Zhang Y; Zhou H
Transl Oncol; 2023 Oct; 36():101739. PubMed ID: 37544033
[TBL] [Abstract][Full Text] [Related]
38. A network pharmacology approach to investigate the mechanism of Shuxuening injection in the treatment of ischemic stroke.
Cui Q; Zhang YL; Ma YH; Yu HY; Zhao XZ; Zhang LH; Ge SQ; Zhang GW; Qin XD
J Ethnopharmacol; 2020 Jul; 257():112891. PubMed ID: 32315738
[TBL] [Abstract][Full Text] [Related]
39. Systematic analysis based on the cuproptosis-related genes identifies ferredoxin 1 as an immune regulator and therapeutic target for glioblastoma.
Dai L; Zhou P; Lyu L; Jiang S
BMC Cancer; 2023 Dec; 23(1):1249. PubMed ID: 38114959
[TBL] [Abstract][Full Text] [Related]
40. Tetraspanins predict the prognosis and characterize the tumor immune microenvironment of glioblastoma.
Li YC; Wu Y; Chen G; Zhu LZ; Luo X; Nie QQ; Zhang L; Zuo CJ
Sci Rep; 2023 Aug; 13(1):13317. PubMed ID: 37587203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
